Back to search

University of British Columbia

Designer probiotic supplementation outcomes on high fat diet

Abstract

dc:description

High fat diets (HFDs) cause insulin resistance, oxidative stress, inflammation, all of which are linked with gut microbial dysbiosis. As a therapy, probiotics can reduce inflammation, oxidative stress and insulin resistance under such conditions. However, for these protective effects, probiotic microbes need to colonize and persist in the gut, especially under conditions of oxidative insult and inflammation. Naturally occurring probiotics have fared poorly thus far. To overcome this challenge, two probiotics, BioColoniz & BioPersist, were created in Dr. Gibson’s laboratory from Lactobacillus reuteri and Escherichia coli Nissle 1917 (EcN) parent strains respectively. BioColoniz is bio-engineered to adhere and colonize the gut while BioPersist possesses a survival advantage by expressing a gene that confers resistance to ambient oxidative insult. We hypothesized that these designer probiotics could improve insulin insensitivity induced by HFDs. C57/Bl6 mice were fed a 40% energy HFD for 6 weeks. Mice were either not gavaged or gavaged with the one of the two probiotics during the study. Subsequently, analysis of BioPersist and Biocoloniz livers revealed lowered oxidative stress biomarker nitrotyrosine. BioPersist livers also demonstrated increased antioxidant (glutathione peroxidase-4) and reduced inflammatory biomarkers (inducible nitric oxide synthase and tumor necrosis factor-α). Mice administered BioPersist also gained the least amount of weight on HFD and demonstrated improved glucose tolerance tests. Improved phosphorylation and abundance of insulin/IGF-I receptor β in both BioPersist and BioColoniz livers were also noted. Furthermore, BioPersist livers had elevated phosphorylation of Akt, a key insulin signaling molecule. Overall, we show an improvement of in vivo glucose homeostasis associated with lower inflammation and oxidative stress in the liver with designer probiotics following a high fat diet. These results indicate that bio-engineered probiotics might be a viable therapeutic option for treating clinical insulin resistance and type 2 diabetes in the future.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Biochemistry and Molecular Biology
Grantor dc:publisher
University of British Columbia
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Dadlani, Hansika

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/77270

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Dadlani, Hansika. Designer probiotic supplementation outcomes on high fat diet. master's thesis, University of British Columbia, 2021. http://hdl.handle.net/2429/77270